Content
Search
Navigation
Sitemap
About us
Pipeline & science
Overview
Obesity
Type 2 Diabetes Mellitus (T2DM)
Acute Ischemic Stroke (AIS)
Our expertise
Overview
Our strategic partners
Global opportunities
Join us
Press releases
Contact
简体中文
Search
简体中文
Navigation
Press releases
11 Oct 2023
Cytokinetics Presents Baseline Characteristics From SEQUOIA-HCM at the HCM Society Scientific Sessions
Read article
28 Sep 2023
JIXING and Wuzhou Announce Distribution Agreement
Read article
27 Sep 2023
JIXING Announces the First Patient Enrolled in Phase 3 Clinical Study of LNZ100 and LNZ101 for the Treatment of Presbyopia in China
Read article
14 Sep 2023
Cytokinetics Announces Start of ACACIA-HCM, a Pivotal Phase 3 Clinical Trial of Aficamten in Patients With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
Read article
03 Aug 2023
JIXING Announces the Approval of the Clinical Trial Application for the Phase 3 Clinical Trial of LNZ100 and LNZ101 for the treatment of Presbyopia in China
Read article
26 Jul 2023
JIXING Announces the Acceptance of the Clinical Trial Application for the Phase 3 Clinical Trial of Aficamten Compared to Metoprolol in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy by the National Medical Products Administration
Read article
Load more
